Circulating phospholipase-A2 activity in obstructive sleep apnea and recurrent tonsillitis

International Journal of Pediatric Otorhinolaryngology

Volumn 76, Issue 4, 2012, Pages 471-474

  Ezzeddini, Rana ^a   Darabi, Masoud ^a   Ghasemi, Babollah ^b   Jabbari, Yalda ^a   Abdollahi, Shahin ^a   Rashtchizadeh, Nadereh ^a   Gharahdaghi, Abasaad ^a   Darabi, Maryam ^c   Ansarin, Masoud ^d   Shaaker, Maghsood ^a   Samadi, Akbar ^a   Karamravan, Jamal ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Inflammation; SPLA2 IIa; Tonsillar hypertrophy

Indexed keywords

PHOSPHOLIPASE A2; SECRETORY PHOSPHOLIPASE A2;

ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SLEEP APNEA SYNDROME; TONSILLECTOMY; TONSILLITIS;

AGE FACTORS; BIOLOGICAL MARKERS; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GROUP II PHOSPHOLIPASES A2; HUMANS; MALE; RECURRENCE; SLEEP APNEA, OBSTRUCTIVE; TONSILLECTOMY; TONSILLITIS;

EID: 84859006665     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2011.12.026     Document Type: Article

References (26)

1. Greenfeld M., Tauman R., DeRowe A., Sivan Y. Obstructive sleep apnea syndrome due to adenotonsillar hypertrophy in infants. Int. J. Pediatr. Otorhinolaryngol. 2003, 67:1055-1060.
2. Aydogan M., Toprak D., Hatun S., Yuksel A., Gokalp A.S. The effect of recurrent tonsillitis and adenotonsillectomy on growth in childhood. Int. J. Pediatr. Otorhinolaryngol. 2007, 71:1737-1742.
3. Derkay C.S., Darrow D.H., LeFebvre S.M. Pediatric tonsillectomy and adenoidectomy procedures. AORN J. 1995, 62:887-904.
4. Serpero L.D., Kheirandish-Gozal L., Dayyat E., Goldman J.L., Kim J., Gozal D. A mixed cell culture model for assessment of proliferation in tonsillar tissues from children with obstructive sleep apnea or recurrent tonsillitis. Laryngoscope 2009, 119:1005-1010.
5. Zhang P.C., Pang Y.T., Loh K.S., Wang D.Y. Comparison of histology between recurrent tonsillitis and tonsillar hypertrophy. Clin. Otolaryngol. Allied Sci. 2003, 28:235-239.
6. Murakami M., Kudo I. Phospholipase A2. J. Biochem. 2002, 131:285-292.
7. Laine V.J., Grass D.S., Nevalainen T.J. Protection by group II phospholipase A2 against Staphylococcus aureus. J. Immunol. 1999, 162:7402-7408.
8. Green J.A., Smith G.M., Buchta R., Lee R., Ho K.Y., Rajkovic I.A., et al. Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis. Inflammation 1991, 15:355-367.
9. Kim J., Bhattacharjee R., Dayyat E., Snow A.B., Kheirandish-Gozal L., Goldman J.L., et al. Increased cellular proliferation and inflammatory cytokines in tonsils derived from children with obstructive sleep apnea. Pediatr. Res. 2009, 66:423-428.
10. Agren K., Andersson U., Nordlander B., Nord C.E., Linde A., Ernberg I., et al. Upregulated local cytokine production in recurrent tonsillitis compared with tonsillar hypertrophy. Acta Otolaryngol. 1995, 115:689-696.
11. Coulthard L.G., Costello J., Robinson B., Shiels I.A., Taylor S.M., Woodruff T.M. Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis. Arthritis Res. Ther. 2011, 13:R42.
12. Dong Z., Liu Y., Scott K.F., Levin L., Gaitonde K., Bracken R.B., et al. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer. Carcinogenesis 2010, 31:1948-1955.
13. Misso N.L., Petrovic N., Grove C., Celenza A., Brooks-Wildhaber J., Thompson P.J. Plasma phospholipase A2 activity in patients with asthma: association with body mass index and cholesterol concentration. Thorax 2008, 63:21-26.
14. Rosenson R.S., Elliott M., Stasiv Y., Hislop C. Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease. Eur. Heart J. 2011, 32:999-1005.
15. van der Giet M., Tolle M., Pratico D., Lufft V., Schuchardt M., Hörl M.P., et al. Increased type IIA secretory phospholipase A(2) expression contributes to oxidative stress in end-stage renal disease. J. Mol. Med. (Berl.) 2010, 88:75-83.
16. Breitling L.P., Koenig W., Fischer M., Mallat Z., Hengstenberg C., Rothenbacher D., et al. Type II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: mendelian randomization study. PLoS One 2011, 6:e22318.
17. Lin M.K., Farewell V., Vadas P., Bookman A.A., Keystone E.C., Pruzanski W. Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients. J. Rheumatol. 1996, 23:1162-1166.
18. Babu A., Meng X., Banerjee A.M., Gamboni-Robertson F., Cleveland J.C., Damle S., et al. Secretory phospholipase A2 is required to produce histologic changes associated with gastroduodenal reflux in a murine model. J. Thorac. Cardiovasc. Surg. 2008, 135:1220-1227.
19. Thommesen L., Sjursen W., Gasvik K., Hanssen W., Brekke O.L., Skattebøl L., et al. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. J. Immunol. 1998, 161:3421-3430.
20. Mansour K.M., Kuypers F.A., Wang T.N., Miller A.M., Larkin S.K., Morris C.R. Secretory phospholipase A(2): a marker of infection in febrile children presenting to a pediatric ED. Am. J. Emerg. Med. 2010, 29:1163-1168.
21. Hansford K.A., Reid R.C., Clark C.I., Tyndall J.D., Whitehouse M.W., Guthrie T., et al. d-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity. Chembiochem 2003, 4:181-185.
22. Nyman K.M., Uhl W., Forsstrom J., Buchler M., Beger H.G., Nevalainen T.J. Serum phospholipase A2 in patients with multiple organ failure. J. Surg. Res. 1996, 60:7-14.
23. Ljungman A.G., Tagesson C., Lindahl M. Endotoxin stimulates the expression of group II PLA2 in rat lung in vivo and in isolated perfused lungs. Am. J. Physiol. 1996, 270:L752-L760.
24. Garces F., Lopez F., Nino C., Fernandez A., Chacin L., Hurt-Camejo E., et al. High plasma phospholipase A2 activity, inflammation markers, and LDL alterations in obesity with or without type 2 diabetes. Obesity (Silver Spring) 2010, 18:2023-2029.
25. Millman R.P., Acebo C., Rosenberg C., Carskadon M.A. Sleep, breathing, and cephalometrics in older children and young adults. Part II - response to nasal occlusion. Chest 1996, 109:673-679.
26. Egeli E., Belli S.B., Oghan F., Ozturk O. Relation of isolated tonsillar hypertrophy with body mass index. ORL J. Otorhinolaryngol. Relat. Spec. 2006, 68:228-231.